Cui Ya, Hong Shebin, Jiang Weidong, Li Xiaojing, Zhou Xingyu, He Xiaoya, Liu Jiaqiang, Lin Kaili, Mao Lixia
Department of Oral & Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, 200011, China.
Bioact Mater. 2024 Jan 12;34:436-462. doi: 10.1016/j.bioactmat.2024.01.001. eCollection 2024 Apr.
Mesoporous bioactive glasses (MBGs), which belong to the category of modern porous nanomaterials, have garnered significant attention due to their impressive biological activities, appealing physicochemical properties, and desirable morphological features. They hold immense potential for utilization in diverse fields, including adsorption, separation, catalysis, bioengineering, and medicine. Despite possessing interior porous structures, excellent morphological characteristics, and superior biocompatibility, primitive MBGs face challenges related to weak encapsulation efficiency, drug loading, and mechanical strength when applied in biomedical fields. It is important to note that the advantageous attributes of MBGs can be effectively preserved by incorporating supramolecular assemblies, miscellaneous metal species, and their conjugates into the material surfaces or intrinsic mesoporous networks. The innovative advancements in these modified colloidal inorganic nanocarriers inspire researchers to explore novel applications, such as stimuli-responsive drug delivery, with exceptional in-vivo performances. In view of the above, we outline the fabrication process of calcium-silicon-phosphorus based MBGs, followed by discussions on their significant progress in various engineered strategies involving surface functionalization, nanostructures, and network modification. Furthermore, we emphasize the recent advancements in the textural and physicochemical properties of MBGs, along with their theranostic potentials in multiple cancerous and non-cancerous diseases. Lastly, we recapitulate compelling viewpoints, with specific considerations given from bench to bedside.
介孔生物活性玻璃(MBGs)属于现代多孔纳米材料类别,因其令人印象深刻的生物活性、吸引人的物理化学性质和理想的形态特征而备受关注。它们在包括吸附、分离、催化、生物工程和医学在内的各种领域具有巨大的应用潜力。尽管原始的MBGs具有内部多孔结构、优异的形态特征和卓越的生物相容性,但在生物医学领域应用时,它们面临着与包封效率低、药物负载和机械强度相关的挑战。需要注意的是,通过将超分子组装体、杂多金属物种及其共轭物纳入材料表面或固有介孔网络中,可以有效地保留MBGs的有利属性。这些改性胶体无机纳米载体的创新进展激发了研究人员探索新的应用,如具有卓越体内性能的刺激响应药物递送。鉴于上述情况,我们概述了基于钙硅磷的MBGs的制备过程,随后讨论了它们在涉及表面功能化、纳米结构和网络改性的各种工程策略方面取得的重大进展。此外,我们强调了MBGs在结构和物理化学性质方面的最新进展,以及它们在多种癌症和非癌症疾病中的诊疗潜力。最后,我们总结了引人注目的观点,并从实验室到临床床边进行了具体考虑。